ArrayExpress Uploader0mousewithdrawal of IL-7nonewithdrawal of IL-7nonewithdrawal of IL-7nonenonenonenonenonenonenonenoneBCR-ABL1-transformationnoneBCR-ABL1-transformationnoneBCR-ABL1-transformationSTI571 in absence of IL-7BCR-ABL1-transformationSTI571 in absence of IL-7BCR-ABL1-transformationSTI571 in absence of IL-7BCR-ABL1-transformationSTI571 in presence of IL-7BCR-ABL1-transformationSTI571 in presence of IL-7BCR-ABL1-transformationSTI571 in presence of IL-7BCR-ABL1-transformation8473arrayexpress_sid8This analysis focused on identifying factors that protect pre-B cells against DNA double strand break (DSB)-mediated DNA damage stress...20498019E-GEOD-21664/profile/8773/arrayexpressuploader215cellimmunoglobulininterleukininterleukin-7Dec.12, 2014FalseE-GEOD-21664_A-AFFY-36transcription-profiling-by-array-of-interleukin-7Transcription profiling by array of interleukin-7-dependent and BCR-ABL1-transformed Mus musculus pre-B cellsNov.24, 2014This analysis focused on identifying factors that protect pre-B cells against DNA double strand break (DSB)-mediated DNA damage stress during pre-B cell differentiation. Differentiation of pre-B cells including immunoglobulin light chain gene recombination were performed by withdrawal of interleukin-7 (IL-7) from IL-7-dependent murine pre-B cells or by inhibition of the BCR-ABL1 kinase activity in BCR-ABL1-transformed pre-B cells. The BCR-ABL1 kinase inhibitor STI571 (Imatinib) was used for the inhibition of BCR-ABL1. IL-7-dependent murine pre-B cells were either cultured in IL-7 (10 ng/ml) or induced to differentiate by withdrawal of IL-7. BCR-ABL1-transformed pre-B cells were either treated with 10 µM STI571 (in absence or presence of 10 ng/ml IL-7) for 16 hours or cultured without STI571. Three samples for each condition were processed.http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-21664http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-21664/samples/